Icahn wins second Biogen board seat - Boston Business Journal:

ogarawo.wordpress.com
Biogen confirmed last week the appointment of Icah allyAlexander J. Denner. At the Biogen was pushing for the reelection of all ofthe company’sa four existing directors on the ballot at its annua shareholders meeting, while Icahn was angling to seat four new Bruce R. Ross, Biogen Idec’s chairman, “We welcome Alexander Denner and Richarcd Mulligan to the board and look forward to working with them to builxd onBiogen Idec’s strongg track record of delivering value.” Mulligan is the Mallinckrodt Professorr of Genetics at and directo of the Harvard Gene Therapy Initiative, according to ’s Web Cambridge, Mass.
-based Biogen said shareholders rejected several of Icahn’se other proposals, including moving the company’s incorporation from Delaware to North Dakota, a move Icahn said would give more powe to shareholders. Biogen officials said it appearx that stockholders also rejected a proposak by Icahn to limiy the size of the boarr to13 directors. Bioge n officials now have the power to enlarge thenow 13-member boarxd as they see fit. Icahj is best known for unsuccessfullu pushing BiogenIdec (Nasdaq: BIIB) to sell itselt in 2008.
Last year, shareholders elected the company’s nomineexs over the slate of investors put up by Biogen Idec’s (NASDAQ: BIIB) stocik was trading at $53.17 in afternoon trading Thursday, down from the previouss day’s close of $53.43 a share.